Sinus Tracts-An Early Sign of Bisphosphonate-Associated Osteonecrosis of the Jaws?

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 3, 2009, Pages 593-601

  Mawardi, Hani ^a   Treister, Nathaniel ^b   Richardson, Paul ^c   Anderson, Kenneth ^c   Munshi, Nikhil ^c   Faiella, Robert A ^d   Woo, Sook Bin ^b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Jerome Lipper Multiple Myeloma Center   (United States)

^d Osterville   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ATENOLOL; ATORVASTATIN; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE GLUCONATE; CLINDAMYCIN; DEXAMETHASONE; DIGOXIN; ENALAPRIL; FLUCONAZOLE; GABAPENTIN; LEVOTHYROXINE; METFORMIN; METOPROLOL; OMEPRAZOLE; PAMIDRONIC ACID; PREDNISONE; PROPRANOLOL DERIVATIVE; SIMVASTATIN; THALIDOMIDE; VALSARTAN; WARFARIN; ZOLEDRONIC ACID;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAW OSTEONECROSIS; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; OSTEOPOROSIS; PROSTATE CANCER; TREATMENT DURATION;

AGED; BONE DENSITY CONSERVATION AGENTS; DENTAL FISTULA; DIPHOSPHONATES; HUMANS; JAW DISEASES; MALE; NEOPLASMS; OSTEONECROSIS; PERIODONTAL POCKET; TOOTH EXTRACTION;

EID: 60549111658     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.09.031     Document Type: Article

References (30)

1. Rodan G.A., and Fleisch H.A. Bisphosphonates: Mechanisms of action. J Clin Invest 97 (1996) 2692
2. Russell R.G. Bisphosphonates: Mode of action and pharmacology. Pediatrics 119 suppl 2 (2007) S150
3. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115
4. Migliorati C.A. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21 (2003) 4253
5. Ruggiero S.L., Mehrotra B., Rosenberg T.J., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527
6. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007 65 (2007) 369
7. Khosla S., Burr D., Cauley J., et al. Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22 (2007) 1479
8. Kyle R.A., Yee G.C., Somerfield M.R., et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 25 (2007) 2464
9. Lipton A., Theriault R.L., Hortobagyi G.N., et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: Long term follow-up of two randomized, placebo-controlled trials. Cancer 88 (2000) 1082
10. Berenson J.R., Lichtenstein A., Porter L., et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med 334 (1996) 488
11. Bamias A., Kastritis E., Bamia C., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors. J Clin Oncol 23 (2005) 8580
12. Jadu F., Lee L., Pharoah M., et al. A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients. Ann Oncol 18 (2007) 2015
13. Wang E.P., Kaban L.B., Strewler G.J., et al. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65 (2007) 1328
14. Zavras A.I., and Zhu S. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: Is it osteonecrosis?. J Oral Maxillofac Surg 64 (2006) 917
15. Lexi-Comp. Alendronate: Drug information (2008), Merck & Co, Whitehouse Station, NJ
16. Marx R.E., Cillo Jr. J.E., and Ulloa J.J. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65 (2007) 2397
17. Woo S.B., Hellstein J.W., and Kalmar J.R. Narrative [corrected] review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753
18. Calhoun K.H., Shapiro R.D., Stiernberg C.M., et al. Osteomyelitis of the mandible. Arch Otolaryngol Head Neck Surg 114 (1988) 1157
19. Neville B.W., Damm D.D., Allen C.M., et al. Osteomyelitis, in Oral and Maxillofacial Pathology. (ed 2) (2002), Saunders, Philadelphia 126
20. D'Silva N.J., Summerlin D.J., Cordell K.G., et al. Metastatic tumors in the jaws: A retrospective study of 114 cases. J Am Dent Assoc 137 (2006) 1667
21. Zachariades N. Neoplasms metastatic to the mouth, jaws and surrounding tissues. J Craniomaxillofac Surg 17 (1989) 283
22. Bedogni A., Saia G., Ragazzo M., et al. Bisphosphonate-associated osteonecrosis can hide jaw metastases. Bone 41 (2007) 942
23. Sambrook P., Olver I., and Goss A. Bisphosphonates and osteonecrosis of the jaw. Aust Fam Physician 35 (2006) 801
24. McMahon R.E., Bouquot J.E., Glueck C.J., et al. Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease. J Oral Maxillofac Surg 65 (2007) 1899
25. Arlet J., and Ficat P. Diagnosis of primary femur head osteonecrosis at stage 1 (preradiologic stage). Rev Chir Orthop Reparatrice Appar Mot 54 (1968) 637
26. Ficat P., and Arlet J. Pre-radiologic stage of femur head osteonecrosis: Diagnostic and therapeutic possibilities. Rev Chir Orthop Reparatrice Appar Mot 59 suppl 1 (1973) 26
27. Jones L.C., and Hungerford D.S. Osteonecrosis: Etiology, diagnosis, and treatment. Curr Opin Rheumatol 16 (2004) 443
28. Marx R.E., Sawatari Y., Fortin M., et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567
29. Woo S.B., Hande K., and Richardson P.G. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353 (2005) 99
30. Junquera L., and Gallego L. Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant?. J Oral Maxillofac Surg 66 (2008) 1516